Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer

NCT02209441 · clinicaltrials.gov ↗

AVAILABLE

Status

OTHER

Sponsor class

Conditions

Gastric Cancer.

Interventions

DRUG: Phase I Dose-finding Study of Sorafenib Study

Sponsor

Chinese Academy of Medical Sciences